Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone plus fluoxetine in obsessive-compulsive disorder
IRCT201103083010N2Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of risperidone and fluoxetine in obsessive compulsive disorder (OCD), sponsored by Kermanshah University of Medical Sciences. Started Sep 2010; status: completed.
02
Drugs
risperidonefluoxetine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT201103083010N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201103083010N2.